NO20065054L - Bazedoksifenaskorbat som selektiv ostrogenreseptormodulator - Google Patents

Bazedoksifenaskorbat som selektiv ostrogenreseptormodulator

Info

Publication number
NO20065054L
NO20065054L NO20065054A NO20065054A NO20065054L NO 20065054 L NO20065054 L NO 20065054L NO 20065054 A NO20065054 A NO 20065054A NO 20065054 A NO20065054 A NO 20065054A NO 20065054 L NO20065054 L NO 20065054L
Authority
NO
Norway
Prior art keywords
bazedoxifenacorbate
estrogen receptor
receptor modulator
selective estrogen
selective
Prior art date
Application number
NO20065054A
Other languages
English (en)
Inventor
Syed Muzafar Shah
Kadum Abdul Nabi Ali
Mahdi Fawzi
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20065054L publication Critical patent/NO20065054L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Det beskrives bazedoksifenaskorbat, blandinger som inneholder dette, dispersjoner derav, blandinger av disse og anvendelser av disse.
NO20065054A 2004-04-08 2006-11-02 Bazedoksifenaskorbat som selektiv ostrogenreseptormodulator NO20065054L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56045404P 2004-04-08 2004-04-08
PCT/US2005/011663 WO2005100315A1 (en) 2004-04-08 2005-04-07 Bazedoxifene ascorbate as selective estrogen receptor modulator

Publications (1)

Publication Number Publication Date
NO20065054L true NO20065054L (no) 2006-11-07

Family

ID=34964936

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065054A NO20065054L (no) 2004-04-08 2006-11-02 Bazedoksifenaskorbat som selektiv ostrogenreseptormodulator

Country Status (16)

Country Link
US (2) US7504394B2 (no)
EP (1) EP1732888A1 (no)
JP (1) JP2007532556A (no)
KR (1) KR20060134146A (no)
CN (1) CN1946689A (no)
AU (1) AU2005233128A1 (no)
BR (1) BRPI0509385A (no)
CA (1) CA2561004A1 (no)
CR (1) CR8616A (no)
EC (1) ECSP066909A (no)
IL (1) IL177957A0 (no)
MX (1) MXPA06011686A (no)
NO (1) NO20065054L (no)
RU (1) RU2006132181A (no)
WO (1) WO2005100315A1 (no)
ZA (1) ZA200608362B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0509385A (pt) * 2004-04-08 2007-09-18 Wyeth Corp composto, composição, métodos de preparar o sal, ea dispensão sólida, de tratar um mamìfero tendo uma doença ou sìndrome associadas com a deficiência de estrogênio ou excesso de estrogênio, uma doença ou distúrbio associados com a proliferação ou desenvolvimento anormal dos tecidos endometriais, de tratar cáncer de mama em um mamìfero, e uma mulher pós-menopáusica quanto a um ou mais distúrbios vasomotores, de reduzir colesterol, e de inibir perda óssea em um mamìfero, dispersão sólida, e, uso de um composto
US20070003623A1 (en) * 2005-06-29 2007-01-04 Wyeth Formulations of conjugated estrogens and bazedoxifene
WO2007072907A1 (ja) * 2005-12-21 2007-06-28 Nec Corporation 階調補正方法、階調補正装置、階調補正プログラム及び画像機器
CZ302358B6 (cs) 2007-07-25 2011-03-30 Zentiva, A. S. Nové soli bazedoxifenu
EP2170289B1 (en) * 2008-03-25 2012-02-15 Formac Pharmaceuticals N.v. Preparation method for solid disupersions
WO2012007453A1 (en) * 2010-07-14 2012-01-19 Sandoz Ag Crystalline compound of 1-[4-(2-azepan-1-ylethoxy)benzyl]-2-(4-hydroxyphenyl)-3-methyl-1h-indol-5-ol
US9212172B2 (en) 2010-09-14 2015-12-15 Dr. Reddy's Laboratories Limited Preparation of crystalline bazedoxifene and its salts
CN103845336B (zh) * 2014-03-24 2016-03-09 江苏知原药业有限公司 一种性能优异的乙酸巴多昔芬组合物
CN106198827B (zh) * 2016-08-11 2018-03-27 齐鲁制药有限公司 高效测定醋酸巴多昔芬及其杂质的药物分析方法
CN108218760A (zh) * 2018-02-26 2018-06-29 福建省微生物研究所 一种巴多昔芬l-乳酸盐的晶型
IT201900001923A1 (it) 2019-02-11 2020-08-11 Erregierre Spa Sali di bazedoxifene utili per la preparazione di bazedoxifene acetato
US11246874B1 (en) 2021-04-20 2022-02-15 Oxygen Biotech LLC Treatment of COVID-19

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US5332727A (en) 1993-04-29 1994-07-26 Birkmayer U.S.A. Stable, ingestable and absorbable NADH and NADPH therapeutic compositions
US5478847A (en) 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
US5811120A (en) 1994-03-02 1998-09-22 Eli Lilly And Company Solid orally administerable raloxifene hydrochloride pharmaceutical formulation
US5552412A (en) 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
US5919800A (en) 1995-02-28 1999-07-06 Eli Lilly And Company Benzothiophene compounds, intermediates, compositions, and methods
US5510357A (en) 1995-02-28 1996-04-23 Eli Lilly And Company Benzothiophene compounds as anti-estrogenic agents
TW397821B (en) 1996-04-19 2000-07-11 American Home Produits Corp 3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof
US5780497A (en) 1996-04-19 1998-07-14 American Home Products Corporation 2-phenyl-1- 4-(amino-1-yl-alk-1-ynyl)-benzyl!-1H-indol-5-ols as estrogenic agents
US5998402A (en) 1996-04-19 1999-12-07 American Home Products Corporation 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
SK281737B6 (sk) 1996-04-19 2001-07-10 American Home Products Corporation 2-fenylindolové zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie
US5880137A (en) 1996-04-19 1999-03-09 American Home Products Corporation 2-phenyl-1- 4-(amino-1-yl-alk-1-ynyl)-benzyl!-1H-indol-5-ols as estrogenic agents
US6005102A (en) 1997-10-15 1999-12-21 American Home Products Corporation Aryloxy-alkyl-dialkylamines
PT1025077E (pt) 1997-10-15 2007-05-31 Wyeth Corp Novas ariloxi-alquil-dialquilaminas
US6479535B1 (en) 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
AR029538A1 (es) * 2000-07-06 2003-07-02 Wyeth Corp Composiciones farmaceuticas de agentes estrogenicos
EP1336602A1 (en) 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
RU2355397C2 (ru) * 2002-06-13 2009-05-20 Уайт Режимы лечения базедоксифеном
BRPI0509385A (pt) * 2004-04-08 2007-09-18 Wyeth Corp composto, composição, métodos de preparar o sal, ea dispensão sólida, de tratar um mamìfero tendo uma doença ou sìndrome associadas com a deficiência de estrogênio ou excesso de estrogênio, uma doença ou distúrbio associados com a proliferação ou desenvolvimento anormal dos tecidos endometriais, de tratar cáncer de mama em um mamìfero, e uma mulher pós-menopáusica quanto a um ou mais distúrbios vasomotores, de reduzir colesterol, e de inibir perda óssea em um mamìfero, dispersão sólida, e, uso de um composto

Also Published As

Publication number Publication date
IL177957A0 (en) 2006-12-31
BRPI0509385A (pt) 2007-09-18
RU2006132181A (ru) 2008-05-20
KR20060134146A (ko) 2006-12-27
US20090137559A1 (en) 2009-05-28
WO2005100315A1 (en) 2005-10-27
US7504394B2 (en) 2009-03-17
EP1732888A1 (en) 2006-12-20
CN1946689A (zh) 2007-04-11
CA2561004A1 (en) 2005-10-27
AU2005233128A1 (en) 2005-10-27
ZA200608362B (en) 2009-09-30
JP2007532556A (ja) 2007-11-15
ECSP066909A (es) 2006-12-20
US20050227964A1 (en) 2005-10-13
CR8616A (es) 2007-03-22
MXPA06011686A (es) 2006-12-14

Similar Documents

Publication Publication Date Title
TW200614594A (en) Multi-portion socket and related apparatuses
NO20083147L (no) Anti-OX40L-antistoffer og fremgangsmater for anvendelse av disse
WO2006051531A3 (en) Radioimaging
EA200702643A1 (ru) Антитела, связывающие tweak
MX2007014669A (es) Extractor para un dispositivo de seguridad.
UA107443C2 (uk) Хімічний спосіб
DK1698640T4 (da) Fremgangsmåde til stabilisering af antistof og antistofpræparat som stabiliseret opløsning.
GB2437859B (en) Codebook generation system and associated methods
GB2430677A8 (en) Novel antigenbinding polypeptides and their uses
WO2007062151A3 (en) Chemical compounds
WO2007062148A3 (en) Chemical compounds
NO20053993D0 (no) Kjemiske forbindelser.
DK1940918T3 (da) Dimercaptanterminerede polythioetherpolymerer og fremgangsmåder til at fremstille og anvende samme
NO20070379L (no) Kjemiske forbindelser
NO20083593L (no) Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse
NO20052613D0 (no) Fremgangsmate, system og anordning for a tilby arbeidsbokomrader som datakilder
WO2007062145A3 (en) Chemical compounds
WO2007062067A3 (en) Chemical compounds
FR2865897B1 (fr) Modulateurs de developpement des champignons mycorhiziens a arbuscules, et applications.
TW200715634A (en) Stable organic devices
NO20053133D0 (no) Kjemiske forbindelser.
DK1637527T3 (da) Cannabinoid receptor modulator.
WO2007062190A3 (en) Chemical compounds
TW200705237A (en) Retention of functionality and operational configuration for a portable data storage dirve
NO20053113D0 (no) Lasbar forsegling.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application